Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
On Tuesday, Cathie Wood's Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccine maker. This move comes amidst a series of upcoming catalysts for the biotech firm.
The MRNA Trade
Ark Invest, through its flagship Ark Innovation ETF (NYSE:ARKK), purchased a whopping 72,800 shares of Moderna. Based on the closing price of $107.41 on the same day, the value of this trade stands at approximately $7.82 million. This move indicates a strong belief in the biotech firm's potential, as Ark Invest has been consistently increasing its holdings in Moderna throughout March.
The buying spree reflected Ark's confidence in Moderna's diversified pipeline beyond its mRNA COVID-19 vaccine, including a next-gen COVID-19 vaccine and other promising candidates. With expectations of vaccine approvals and upcoming investor events, Ark appears to be anticipating further growth potential despite Moderna's recent market performance.
Over 12 months Moderna stock has declined 26.89%, however, since 2024 started the stock has gained 8%.
Other Key Trades:
- The ARKG fund sold 1,770 shares of Nvidia Corp (NASDAQ:NVDA). That trade, made through ARK Genomic Revolution ETF (NYSE:ARKG), was valued at $1.63 million.
- Ark Invest's ARKF fund bought shares of Roblox Corp (NYSE:RBLX).
- ARKG also bought shares of Recursion Pharmaceuticals (NASDAQ:RXRX). ARKK purchased 60,9626 shares of Recursion Pharmaceuticals. ARKQ sold shares of Trimble Inc (NASDAQ:TRMB).
On Tuesday, Cathie Wood's Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccine maker. This move comes amidst a series of upcoming catalysts for the biotech firm.
週二，凱西·伍德旗下的方舟投資採取了重大舉措，增加了其在領先的 COVID-19 疫苗生產商摩德納公司（納斯達克股票代碼：MRNA）的股份。此舉是在這家生物技術公司即將推出的一系列催化劑之際採取的。
The MRNA Trade
MRNA 交易
Ark Invest, through its flagship Ark Innovation ETF (NYSE:ARKK), purchased a whopping 72,800 shares of Moderna. Based on the closing price of $107.41 on the same day, the value of this trade stands at approximately $7.82 million. This move indicates a strong belief in the biotech firm's potential, as Ark Invest has been consistently increasing its holdings in Moderna throughout March.
方舟投資通過其旗艦方舟創新ETF（紐約證券交易所代碼：ARKK）購買了高達72,800股Moderna的股票。根據當天107.41美元的收盤價，該交易的價值約爲782萬美元。此舉表明人們堅信這家生物技術公司的潛力，因爲方舟投資在整個三月份一直在增加其在Moderna的持股。
The buying spree reflected Ark's confidence in Moderna's diversified pipeline beyond its mRNA COVID-19 vaccine, including a next-gen COVID-19 vaccine and other promising candidates. With expectations of vaccine approvals and upcoming investor events, Ark appears to be anticipating further growth potential despite Moderna's recent market performance.
此次收購狂潮反映了方舟對Moderna除mRNA COVID-19 疫苗之外的多元化產品線的信心，包括下一代 COVID-19 疫苗和其他有前途的候選疫苗。儘管Moderna最近表現出色，但由於對疫苗批准和即將舉行的投資者活動的預期，Ark似乎預計會有進一步的增長潛力。
Over 12 months Moderna stock has declined 26.89%, however, since 2024 started the stock has gained 8%.
在過去的12個月中，Moderna的股票下跌了26.89％，但是，自2024年開始以來，該股已經上漲了8％。
Other Key Trades:
其他關鍵交易：
- The ARKG fund sold 1,770 shares of Nvidia Corp (NASDAQ:NVDA). That trade, made through ARK Genomic Revolution ETF (NYSE:ARKG), was valued at $1.63 million.
- Ark Invest's ARKF fund bought shares of Roblox Corp (NYSE:RBLX).
- ARKG also bought shares of Recursion Pharmaceuticals (NASDAQ:RXRX). ARKK purchased 60,9626 shares of Recursion Pharmaceuticals. ARKQ sold shares of Trimble Inc (NASDAQ:TRMB).
- ARKG基金出售了英偉達公司（納斯達克股票代碼：NVDA）的1,770股股票。這筆交易是通過方舟基因革命ETF（紐約證券交易所代碼：ARKG）進行的，價值163萬美元。
- 方舟投資的ARKF基金購買了Roblox公司（紐約證券交易所代碼：RBLX）的股票。
- ARKG還購買了Recursion Pharmicals（納斯達克股票代碼：RXRX）的股票。ARKK購買了Recursion Pharmicals的60,9626股股票。ARKQ出售了天寶公司（納斯達克股票代碼：TRMB）的股票。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧